
High dose isoflavon during prostate cancer therapy ADT may risk of Sexual
Dysfunction
-
Recent study from Georgetown University, Washington, DC, reported that
Prostate Cancer Therapy with profound hypogonadism due to Androgen
Deprivation Thera...